Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stock Market Today Live, July 9: Sensex up 450 pts, trades at 76,956.50; Nifty up 155 pts; Sun Pharma, SBI Life, Bajaj Finserv top gainers - BusinessLine
Stock Market Today Live, July 9: Sensex up 450 pts, trades at 76,956.50; Nifty up 155 pts; Sun Pharma, SBI Life, Bajaj Finserv top gainersBusinessLine
Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why
Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.
Sun Pharmaceutical Industries Ltd spurts 0.07%, up for five straight sessions
Sun Pharmaceutical Industries Ltd is quoting at Rs 1914.2, up 0.07% on the day as on 12:44 IST on the NSE. The stock is up 14.45% in last one year as compared to a 4.11% fall in NIFTY and a 16.43% fall in the Nifty Pharma.
Poly Medicure among 4 stocks that closed below VWAP
Four Nifty500 stocks, Poly Medicure, Aditya Birla Real Estate, Siemens Energy India, and Onesource Specialty Pharma, closed over 2% below their VWAP on July 3, indicating potential bearish momentum and heightened selling pressure, according to technical scan data.
Dividend alert! Last day to buy JSW Steel, Sun Pharma, 4 more stocks to earn payouts up to Rs 75
JSW Steel has fixed Tuesday as the record date for its final dividend of Rs 7.1 per share for the financial year 2026. Once approved by the shareholders during its upcoming Annual General Meeting (AGM), the said dividend will be paid within 30 days from the date of its declaration, the company said.
10 smallcap stocks soar up to 212% this year, 3 turn multibaggers. Do you own any?
India's smallcap stocks have outperformed the Nifty 50 in 2026, with HFCL, Aditya Infotech and Acutaas Chemicals leading the top 10 performers, delivering exceptional year-to-date returns.
Health ministry issues proposal for one-year residual shelf life for imported drugs
The Union Health Ministry is proposing to relax import rules for medicines, requiring a minimum 12-month shelf life upon arrival instead of the current 60% of total shelf life. This move aims to simplify business operations and ensure medicine availability. The change, however, will not affect specialized drugs like biologicals and radiopharmaceuticals. Officials believe this will cut down wastage and improve inventory management, ultimately benefiting patients.
Sun Pharmaceutical Industries Ltd spurts 1.19%, rises for fifth straight session
Sun Pharmaceutical Industries Ltd is quoting at Rs 1885, up 1.19% on the day as on 12:44 IST on the NSE. The stock is up 13.44% in last one year as compared to a 4.38% drop in NIFTY and a 15.7% drop in the Nifty Pharma.
Hindalco appoints Kapil Agrawal as CEO (Designate) for copper business; Rohit Pathak to move to new role
Hindalco Industries has appointed Kapil Agrawal as CEO (Designate) – Copper with effect from November 1, 2026. He will take over as CEO of the Copper business from March 1, 2027, succeeding Rohit Pathak, who will transition to a new role within the Aditya Birla Group.
AB Group reaffirms bet on Voda Idea with ₹4,730 Cr infusion
Vodafone Idea shareholders approved a ₹4,730-crore investment from the Aditya Birla Group via preferential allotment of warrants, increasing AB Group's stake to around 13%. Chairman Kumar Mangalam Birla stated the company's focus now shifts to execution across operations, customer service, and network expansion. This capital infusion will support capital expenditure and loan repayment, reinforcing Vi's financial health.
Market Trading Guide: Akums Drugs among 4 stock recommendations for Thursday
Domestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain bullish on Akums Drugs and Aditya Birla Sun Life AMC after strong technical breakouts, rising volumes and improving momentum indicators.
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.